Chongkundang
₩57,400
1
+₩0+0% Today
Statistics
Day High
57,400
Day Low
57,200
52W High
64,300
52W Low
47,150
Volume
138
Avg. Volume
2,811
Mkt Cap
-
P/E Ratio
-
Dividend Yield
2.43%
Dividend
1,395.14
Upcoming
13
NOV
Earnings
27
DEC
Dividend Ex
Estimated
6
APR 25
Dividend Payment
Estimated
27
DEC 25
Dividend Ex
Estimated
6
APR 26
Dividend Payment
Estimated
Dividends
2.43%Dividend Yield
10Y Growth
7.18%
5Y Growth
1.49%
3Y Growth
N/A
1Y Growth
N/A
Earnings
13NovExpected
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 001630.KQ. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
Show more...
CEO
Mr. Young-Joo Kim
Employees
2335
Country
South Korea
ISIN
KR7001630003